ArticleInternational journal of dermatology2026
Neuropsychiatric Outcomes of IL-17 and IL-23 Inhibitors in Dermatology: Risks, Benefits, and Clinical Implications.
Isabella J Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.